Form 4: Director Robert L. Dixon Jr. Sells Elevance Health Shares

Elevance Health Director Robert L. Dixon Jr. sold 151 shares of common stock at a price of $401.77 per share.

Summary

• Director Robert L. Dixon Jr. executed a sale of 151 shares of Elevance Health (ELV) common stock.
• The transaction occurred on June 11, 2026.
• The shares were sold at a price of $401.77 per share.
• Following this transaction, the director retains beneficial ownership of 10,734 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction size is negligible and appears to be a routine personal financial decision.

Positives

• The transaction represents a minor reduction in the director's total holdings, suggesting it is likely a routine portfolio adjustment rather than a signal of lack of confidence.

Negatives

• Insider selling can sometimes be perceived negatively by retail investors as a lack of long-term conviction, though this specific sale is small in volume.

Risks

• None identified in this specific Form 4 filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling by directors is common practice for liquidity or tax planning and does not necessarily reflect the company's operational health or future performance.

Comparison to Industry Standards

• The sale of 151 shares is statistically insignificant relative to the total market capitalization of Elevance Health.
• Director selling activity is consistent with standard corporate governance practices where insiders periodically rebalance their equity holdings.

Stakeholder Impact

• Minimal impact on shareholders given the small volume of shares sold.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Elevance Health, ELV, Insider Trading, Form 4, Director Sale, Healthcare